Ocular Surgery News

07/27/2025

Look back at ’s top debates:

Is systemic therapy the best option for uveitic macular edema? 🤔

https://www.healio.com/news/ophthalmology/20250722/specialists-debate-systemic-vs-local-treatment-of-uveitic-macular-edema

SEVILLE, Spain — Treatments for uveitic macular edema, including systemic and local options, were among the topics debated at the Congress on Controversies in Ophthalmology.

07/26/2025

Dr. Julia A. Haller has been named CEO of Wills Eye Hospital.

Dr. Haller spoke with Healio about her commitment to continuing the hospital’s historic legacy. 🔗👇

https://www.healio.com/news/ophthalmology/20250725/julia-a-haller-md-new-wills-eye-ceo-hopes-to-continue-to-recruit-best-and-brightest
Wills Eye Hospital

07/25/2025

Check out Clinical Guidance’s new module to help recognize AMD as a leading cause of vision loss, with dry and neovascular types. https://www.healio.com/clinical-guidance/age-related-macular-degeneration

07/25/2025

❗From ❗

Dr. Michael Javaheri overviews positive findings from four studies investigating Eylea HD in diabetic macular edema and wet AMD.

Full video on Healio:

https://www.healio.com/news/ophthalmology/20250724/eylea-hd-extends-dosing-intervals-in-dme-wet-amd

07/25/2025

❗EXCLUSIVE❗

Work is still needed to find durable, easily administered therapies with few side effects.

To that end, must work with to manage patients through every step of their journey.

https://www.healio.com/news/ophthalmology/20250725/treatment-for-thyroid-eye-disease-in-an-exciting-era-of-growth
Baylor College of Medicine Cedars-Sinai Healio

07/24/2025

❗From ❗

The Tecnis Odyssey IOL improves at all ranges.

Brian Schwam, MD, of Johnson & Johnson - Vision shared the data with Healio.👇

https://www.healio.com/news/ophthalmology/20250724/tecnis-odyssey-iol-improves-vision-at-all-ranges
American Society of Cataract and Refractive Surgery (ASCRS)

07/24/2025

❗Today is the final day to preregister for the Women in Ophthalmology Summer Symposium in Amelia Island, Fla.❗

Physicians can attend scientific sessions, career development courses, wet labs and even a pickleball tournament.

Full meeting preview 👇

https://www.healio.com/news/ophthalmology/20250718/wio-summer-symposium-encourages-attendees-to-learn-laugh-lift

07/24/2025

A study looked at the impact of age and s*x on retinal vascular changes in patients with .

What did the results, collected from more than 80,000 fundus images, show?

https://www.healio.com/news/ophthalmology/20250723/video-age-s*x-may-affect-retinal-vasculature-in-glaucoma
University of Maryland School of Medicine Healio

07/23/2025

❗Healio Exclusive Q&A❗

KeraLink International’s 30/30/30 initiative not only aims to eradicate corneal , but to raise women to leadership roles in underserved communities.

Find out more. 🔗

https://www.healio.com/news/ophthalmology/20250715/qa-keralink-international-takes-on-corneal-blindness-through-strategic-initiatives

07/23/2025

The Omni Edge Surgical System for debuted at .

It offers “safe, reproducible and predictable” deployment of viscoelastic fluid into Schlemm’s canal, Mark Papini of Sight Sciences told Healio.

https://www.healio.com/news/ophthalmology/20250722/omni-edge-provides-comprehensive-glaucoma-treatment-increased-viscoelastic-capacity
American Society of Cataract and Refractive Surgery (ASCRS)

07/22/2025

Use Clinical Guidance to implement regular geographic atrophy monitoring and coordinated referrals for retina or low-vision specialists based on disease progression, symptom burden, and patient goals. https://www.healio.com/clinical-guidance/geographic-atrophy

07/22/2025

❗BREAKING❗

In a phase 2 trial, Cloudbreak Pharma’s preservative-free improved conjunctival hyperemia in patients with vascularized pinguecula.

More on Healio:

https://www.healio.com/news/ophthalmology/20250722/phase-2-trial-preservativefree-eye-drop-promising-for-vascularized-pinguecula-hyperemia

Cloudbreak Pharma reported positive topline results from a phase 2 clinical trial that assessed a preservative-free ophthalmic solution for the treatment of vascularized pinguecula and associated conjunctival hyperemia.